Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erlotinib and bevacizumab have synergistic activity against melanoma.
Schicher N, Paulitschke V, Swoboda A, Kunstfeld R, Loewe R, Pilarski P, Pehamberger H, Hoeller C. Schicher N, et al. Among authors: hoeller c. Clin Cancer Res. 2009 May 15;15(10):3495-502. doi: 10.1158/1078-0432.CCR-08-2407. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447871
Chemosensitisation of malignant melanoma by BCL2 antisense therapy.
Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K, Pehamberger H. Jansen B, et al. Among authors: hoeller c. Lancet. 2000 Nov 18;356(9243):1728-33. doi: 10.1016/S0140-6736(00)03207-4. Lancet. 2000. PMID: 11095261 Clinical Trial.
Clusterin regulates drug-resistance in melanoma cells.
Hoeller C, Pratscher B, Thallinger C, Winter D, Fink D, Kovacic B, Sexl V, Wacheck V, Gleave ME, Pehamberger H, Jansen B. Hoeller C, et al. J Invest Dermatol. 2005 Jun;124(6):1300-7. doi: 10.1111/j.0022-202X.2005.23720.x. J Invest Dermatol. 2005. PMID: 15955107 Free article.
87 results